Amblyopia

Jonathan M. Holmes, Michael P. Clarke

Research output: Contribution to journalReview article

242 Scopus citations

Abstract

Results from recent randomised clinical trials in amblyopia should change our approach to screening for and treatment of amblyopia. Based on the current evidence, if one screening session is used, screening at school entry could be the most reasonable time. Clinicians should preferably use age-appropriate LogMAR acuity tests, and treatment should only be considered for children who are clearly not in the typical range for their age. Any substantial refractive error should be corrected before further treatment is considered and the child should be followed in spectacles until no further improvement is recorded, which can take up to 6 months. Parents and carers should then be offered an informed choice between patching and atropine drops. Successful patching regimens can last as little as 1 h or 2 h a day, and successful atropine regimens as little as one drop twice a week. Intense and extended regimens might not be needed in initial therapy.

Original languageEnglish (US)
Pages (from-to)1343-1351
Number of pages9
JournalLancet
Volume367
Issue number9519
DOIs
StatePublished - Apr 22 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Amblyopia'. Together they form a unique fingerprint.

  • Cite this

    Holmes, J. M., & Clarke, M. P. (2006). Amblyopia. Lancet, 367(9519), 1343-1351. https://doi.org/10.1016/S0140-6736(06)68581-4